Doesnt offer DTC diagnostics or prescriptions
Jolanda van Hal November in review: GLP-1 breakthroughs, UPFs under fire, Novonesis advances healthy longevity Jolanda van Hal Key takeaways GLP-1 science, product pipelines, and consumer acceptance reached a pivotal point in November, reshaping nutrition, pharma, and metabolic health
It is important to find an exercise plan that works for you and stick with it
Compounded GLP-1s arent right for everyone, and your full medical history matters.
Additionally, increasing government initiatives focused on obesity management and supportive regulatory frameworks are facilitating faster drug approvals and market penetration
While packaged foods offer convenience, particularly for those living alone or with limited cooking time, consumers must be wary of hidden ingredients like sugar or sodium